PLYMOUTH MEETING, Pa., Feb. 12, 2026
PLYMOUTH MEETING, Pa., Feb. 12, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will participate in the following scientific and investor conferences:
American Association for Cancer Research Immuno-Oncology Conference (Los Angeles, CA)
Date: Wednesday, February 18
Time: 7:30-10 PM PT, Poster Session A
Poster Presentation: Treatment of RRP with DNA immunotherapy INO-3107 induces activation and enrichment of pro-inflammatory CD4+ T cell responses in blood and airways of patients with clinical response
Oppenheimer 36th Annual Healthcare Life Sciences Conference (Virtual)
Date: Wednesday, February 25
Time: 12:40 -1:10 PM ET
Format: Fireside Chat
Webcast: https://event.summitcast.com/view/CTtthLh2Bi2D9aYoKpvtEv/degYsHNqjq4UMJYMr4minN
Festival of Biologics (San Diego, CA)
Date: Wednesday, March 4
Time: 3:10 PM PT
Presentation: Safety and Pharmacokinetics of SARS-CoV-2 DNA-Encoded Monoclonal Antibodies (DMAbs) in Healthy Adults: A Phase 1 Trial
Citizens Life Sciences Conference (Miami Beach, FL)
Date: Tuesday, March 10
Time: 1:40 – 2:05 PM ET
Format: Fireside Chat
Webcast: https://event.summitcast.com/view/BuMiPNPtyHKimMF6k4AFMd/j7XuLLN6VFvrBMcQmqB55w
Available abstracts will be shared on INOVIO's website following presentations. Replay of the investor events will be available for 90 days at the links above and on the INOVIO events page. Members of INOVIO's management team will also be conducting one-on-one meetings with investors during the investor conferences.
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.
Contacts
Media: Jennie Willson, (267) 429-8567, communications@inovio.com
Investors: Peter Vozzo, ICR Healthcare, (443) 213-0505, investor.relations@inovio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-upcoming-scientific-and-investor-conferences-302685788.html
SOURCE INOVIO Pharmaceuticals, Inc.
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
